Internal Medicine, Hematology & Oncology · Port Huron, MI
NPI
1063453413
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1231 Pine Grove Ave, Ste 2f
Port Huron, MI, 48060
Phone (810) 982-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$902K
62,263 services
Medicare patients, 2024
494
Average age 74
Drug cost, 2024
$7.6M
2,338 prescriptions
Company payments, 2025
$792
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samir Alsawah was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 24,990 times for 35 patients. In total Samir Alsawah billed 62,263 services in 99 codes, and Medicare paid $902K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 24,990 | 35 | $0.28 | $7,009 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 595 | 32 | $0.09 | $53.6 |
| 85025 Blood Count | Office | 585 | 188 | $7.60 | $4,444 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 490 | 27 | $0.69 | $338 |
| 99214 Office E&M - Established | Office | 336 | 185 | $95.20 | $32K |
| 96367 Intravenous Infusion, Hydration | Office | 229 | 42 | $22.37 | $5,122 |
| 36415 Venipuncture Blood Collection | Office | 172 | 73 | $8.65 | $1,488 |
| 96413 Chemotherapy Administration | Office | 170 | 56 | $100.06 | $17K |
| 99215 Office E&M - Established | Office | 157 | 71 | $141.86 | $22K |
| 96372 Injection Administration | Office | 137 | 43 | $10.86 | $1,488 |
| 99214 Office E&M - Established | Facility | 135 | 82 | $67.74 | $9,145 |
| 96375 Injection Administration | Office | 86 | 39 | $12.12 | $1,042 |
| 99213 Office E&M - Established | Office | 76 | 54 | $65.45 | $4,974 |
| J3490 Unclassified drugs | Office | 75 | 36 | $0.56 | $41.93 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 63 | 20 | $0.65 | $40.91 |
By year: 2022 $1.6M for 105,501 services; 2023 $1.1M for 75,903 services; 2024 $902K for 62,263 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 585 | 188 | $7.60 | $4,444 |
| 36415 Venipuncture Blood Collection | 172 | 73 | $8.65 | $1,488 |
Medicare prescription drug claims, 2024
In 2024, the drug Samir Alsawah prescribed most often to Medicare patients was Letrozole, with 265 prescriptions and refills. In total Samir Alsawah wrote 2,338 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 265 | 617 | 78 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 112 | 112 | 41 | $1,783 |
| Alprazolam Generic | 79 | 85 | 22 | $432 |
| Eliquis Apixaban | 78 | 106 | 19 | $60K |
| Levothyroxine Sodium Generic | 67 | 119 | 20 | $593 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 63 | 63 | Under 11 | $2,261 |
| Hydroxyurea Generic | 61 | 125 | 13 | $1,644 |
| Exemestane Generic | 56 | 154 | 20 | $17K |
| Gabapentin Generic | 54 | 62 | 18 | $472 |
| Calquence Acalabrutinib Maleate | 53 | 53 | Under 11 | $781K |
| Tasigna Nilotinib Hcl | 50 | 50 | Under 11 | $876K |
| Raloxifene Hcl Generic | 50 | 142 | 18 | $2,990 |
| Xarelto Rivaroxaban | 48 | 98 | Under 11 | $52K |
| Tramadol Hcl Generic | 44 | 44 | 16 | $324 |
| Oxycodone Hcl Generic | 43 | 43 | Under 11 | $1,443 |
Brand drugs: 728 claims; generic drugs: 1,610 claims; opioid claims: 335.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samir Alsawah $792 ($792 in general payments such as food, travel and fees) from 15 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $135.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $135 |
| Geron Corporation GERN | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $87.76 |
| Genzyme Corporation SNY | 1 | $76.76 |
| Array Biopharma Inc PFE | 3 | $68.42 |
| Janssen Biotech, Inc. JNJ | 3 | $67.18 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $48.24 |
| Pfizer Inc. PFE | 2 | $39.07 |
| GlaxoSmithKline, LLC. GSK | 1 | $24.89 |
| Kite Pharma, Inc. GILD | 1 | $24.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.